4/A//SEC Filing
DiCorleto Paul E 4/A
Accession 0001144204-10-020878
CIK 0001318641other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 4:36 PM ET
Size
5.6 KB
Accession
0001144204-10-020878
Insider Transaction Report
Form 4/AAmended
DiCorleto Paul E
Director
Transactions
- Award
Stock Options (Right to Buy)
2009-06-25+35,000→ 105,000 totalExercise: $3.33From: 2009-06-25Exp: 2019-06-24→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The exercise price of the stock options reported on the Form 4 filed on June 26, 2009 was incorrectly reported as $3.41. The actual exercise price of these stock options is $3.33. This amendment is being filed solely to correct the exercise price.
Documents
Issuer
CLEVELAND BIOLABS INC
CIK 0001318641
Entity typeother
Related Parties
1- filerCIK 0001370082
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 4:36 PM ET
- Size
- 5.6 KB